Uveitis screening: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(11 intermediate revisions by 3 users not shown)
Line 2: Line 2:
{{Uveitis}}
{{Uveitis}}
{{CMG}}; {{AE}}{{TarekNafee}}
{{CMG}}; {{AE}}{{TarekNafee}}
==Overview==
==Overview==
There is insufficient evidence to recommend routine screening for uveitis for the general population. For patients diagnosed with or suspected of having [[juvenile idiopathic arthritis|juvenile idiopathic arthritis (JIA)]], screening guidelines have been recommended by the American Academy of Pediatrics (AAP) and the British Society of Paediatrics and Rheumatology (BSPAR).<ref name="pmid25825278">{{cite journal| author=Sen ES, Dick AD, Ramanan AV| title=Uveitis associated with juvenile idiopathic arthritis. | journal=Nat Rev Rheumatol | year= 2015 | volume= 11 | issue= 6 | pages= 338-48 | pmid=25825278 | doi=10.1038/nrrheum.2015.20 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25825278  }} </ref><ref name="pmid16651348">{{cite journal| author=Cassidy J, Kivlin J, Lindsley C, Nocton J, Section on Rheumatology. Section on Ophthalmology| title=Ophthalmologic examinations in children with juvenile rheumatoid arthritis. | journal=Pediatrics | year= 2006 | volume= 117 | issue= 5 | pages= 1843-5 | pmid=16651348 | doi=10.1542/peds.2006-0421 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16651348  }} </ref>


==Screening==
==Screening==
There is insufficient evidence to recommend routine screening for uveitis for the general population. For patients diagnosed with systematic conditions strongly associated with uveitis, there are guidelines for screening for uveitis in asymptomatic patients. This includes:<br>
There is insufficient evidence to recommend routine screening for uveitis for the general population.<ref name=uspstfuveitis>U.S. Preventative Services Task Force Recommendations (2016)http://www.uspreventiveservicestaskforce.org/BrowseRec/Index/browse-recommendations</ref> For patients diagnosed with, or suspected of having [[juvenile idiopathic arthritis|juvenile idiopathic arthritis (JIA)]], screening guidelines have been recommended based on the AAP, Cincinnati Children's Hospital, and the BSPAR. Screening for uveitis in children with [[juvenile idiopathic arthritis|JIA]] is recommended as follows:
'''[[Juvenile idiopathic arthritis]]'''
 
Based on Cincinnati Children's Hospital BESt evidence guidelines, screening for uveitis in children with JIA is recommended as follows:<br>
*Patients should be referred at the time of diagnosis or suspicion of [[juvenile idiopathic arthritis|JIA]], and a slit lamp ophthalmologic examination be performed within one month to 6 weeks of referral. It is recommended that after the initial screening examination, regular follow-up screenings be maintained based on risk category and classification.
It is recommended that a referral for an initial screening examination for uveitis be made by the rheumatology provider upon diagnosis of JIA, and the exam be performed within one month after diagnosis of JIA. It is recommended that after the initial screening examination, regular follow-up screenings be maintained based on risk category and classification.
 
For access to the complete guideline, click [[Media:Jiauveitisscreening.pdf|here]]
For access to the complete American guideline,'''[[Media:Jiauveitisscreening.pdf|click here]]'''.<ref name="pmid16651348">{{cite journal| author=Cassidy J, Kivlin J, Lindsley C, Nocton J, Section on Rheumatology. Section on Ophthalmology| title=Ophthalmologic examinations in children with juvenile rheumatoid arthritis. | journal=Pediatrics | year= 2006 | volume= 117 | issue= 5 | pages= 1843-5 | pmid=16651348 | doi=10.1542/peds.2006-0421 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16651348  }} </ref>
'''[[Sarcoidosis]]'''
 
For access to the complete British guideline,'''[[Media:Bsparuveitis.pdf|click here]]'''.<ref name="pmid25825278">{{cite journal| author=Sen ES, Dick AD, Ramanan AV| title=Uveitis associated with juvenile idiopathic arthritis. | journal=Nat Rev Rheumatol | year= 2015 | volume= 11 | issue= 6 | pages= 338-48 | pmid=25825278 | doi=10.1038/nrrheum.2015.20 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25825278  }} </ref>


== References ==
== References ==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Ophthalmology]]
[[Category:Primary care]]


{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Ophthalmology]]
[[Category:FinalQCRequired]]
[[Category:Emergency mdicine]]
[[Category:Disease]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]

Latest revision as of 00:37, 30 July 2020

Uveitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Uveitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Uveitis screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Uveitis screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Uveitis screening

CDC on Uveitis screening

Uveitis screening in the news

Blogs on Uveitis screening

Directions to Hospitals Treating Uveitis

Risk calculators and risk factors for Uveitis screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Tarek Nafee, M.D. [2]

Overview

There is insufficient evidence to recommend routine screening for uveitis for the general population. For patients diagnosed with or suspected of having juvenile idiopathic arthritis (JIA), screening guidelines have been recommended by the American Academy of Pediatrics (AAP) and the British Society of Paediatrics and Rheumatology (BSPAR).[1][2]

Screening

There is insufficient evidence to recommend routine screening for uveitis for the general population.[3] For patients diagnosed with, or suspected of having juvenile idiopathic arthritis (JIA), screening guidelines have been recommended based on the AAP, Cincinnati Children's Hospital, and the BSPAR. Screening for uveitis in children with JIA is recommended as follows:

  • Patients should be referred at the time of diagnosis or suspicion of JIA, and a slit lamp ophthalmologic examination be performed within one month to 6 weeks of referral. It is recommended that after the initial screening examination, regular follow-up screenings be maintained based on risk category and classification.

For access to the complete American guideline,click here.[2]

For access to the complete British guideline,click here.[1]

References

  1. 1.0 1.1 Sen ES, Dick AD, Ramanan AV (2015). "Uveitis associated with juvenile idiopathic arthritis". Nat Rev Rheumatol. 11 (6): 338–48. doi:10.1038/nrrheum.2015.20. PMID 25825278.
  2. 2.0 2.1 Cassidy J, Kivlin J, Lindsley C, Nocton J, Section on Rheumatology. Section on Ophthalmology (2006). "Ophthalmologic examinations in children with juvenile rheumatoid arthritis". Pediatrics. 117 (5): 1843–5. doi:10.1542/peds.2006-0421. PMID 16651348.
  3. U.S. Preventative Services Task Force Recommendations (2016)http://www.uspreventiveservicestaskforce.org/BrowseRec/Index/browse-recommendations

Template:WH Template:WS